Shares of BMO Capital Markets (:) have been assigned a consensus rating of “N/A” from the zero ratings firms that are presently covering the firm, Marketbeat Ratings reports.
COPYRIGHT VIOLATION NOTICE: This article was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/08/19/acelrx-pharmaceuticals-inc-nasdaqacrx-expected-to-announce-earnings-of-0-28-per-share-updated-updated-updated.html.
BMO Capital Markets Company Profile
BMO Capital Markets is the investment banking and capital markets arm of Bank of Montreal, aka BMO Financial Group. It serves corporate, institutional, and government clients in North America, providing equity and debt underwriting, corporate lending and project finance, M&A advisory, and equity and debt research.
What are top analysts saying about BMO Capital Markets? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for BMO Capital Markets and related companies.